Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Takeda Pharmaceuticals Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (111)
Cancellation by sponsor (38)
Prescription medicine registration (12)
Australian Public Assessment Report (AusPAR) (10)
Designation or determination (5)
Prescription medicine decision summary (2)
Prescription medicine evaluation (1)

Date

2024 (9)
2023 (7)
2022 (14)
2021 (14)
2020 (13)
2019 (17)
2018 (6)
2017 (34)
2016 (5)
2015 (5)
2014 (14)
2013 (11)
2012 (3)
2010 (1)
2009 (2)
2008 (8)
2007 (2)
2006 (1)
2005 (9)
2002 (1)
2000 (2)
1999 (1)

Results for "[search-keyword]"

Search

Sponsor content

179 result(s) found, displaying 101 to 110

NESINA PIO 25/15 25 mg alogliptin (as benzoate) / 15 mg pioglitazone (as hydrochloride) film-coated tablet blister pack Cancelled under s30(1)(c)

4 December 2017

Cancellation by sponsor

Requested by Takeda Pharmaceuticals Australia Pty Ltd
NESINA PIO 12.5/30 12.5 mg alogliptin (as benzoate) / 30 mg pioglitazone (as hydrochloride) film-coated tablet bottle Cancelled under s30(1)(c)

4 December 2017

Cancellation by sponsor

Requested by Takeda Pharmaceuticals Australia Pty Ltd
NESINA PIO 25/15 25 mg alogliptin (as benzoate) / 15 mg pioglitazone (as hydrochloride) film-coated tablet bottle Cancelled under s30(1)(c)

4 December 2017

Cancellation by sponsor

Requested by Takeda Pharmaceuticals Australia Pty Ltd
NESINA PIO 12.5/45 12.5 mg alogliptin (as benzoate) / 45 mg pioglitazone (as hydrochloride) film-coated tablet blister pack Cancelled under s30(1)(c)

4 December 2017

Cancellation by sponsor

Requested by Takeda Pharmaceuticals Australia Pty Ltd
NESINA PIO 25/30 25 mg alogliptin (as benzoate) / 30 mg pioglitazone (as hydrochloride) film-coated tablet blister pack Cancelled under s30(1)(c)

4 December 2017

Cancellation by sponsor

Requested by Takeda Pharmaceuticals Australia Pty Ltd
NESINA PIO 25/45 25 mg alogliptin (as benzoate) / 45 mg pioglitazone (as hydrochloride) film-coated tablet blister pack Cancelled under s30(1)(c)

4 December 2017

Cancellation by sponsor

Requested by Takeda Pharmaceuticals Australia Pty Ltd
NESINA PIO 12.5/30 12.5 mg alogliptin (as benzoate) / 30 mg pioglitazone (as hydrochloride) film-coated tablet blister pack Cancelled under s30(1)(c)

4 December 2017

Cancellation by sponsor

Requested by Takeda Pharmaceuticals Australia Pty Ltd
NESINA PIO 25/30 25 mg alogliptin (as benzoate) / 30 mg pioglitazone (as hydrochloride) film-coated tablet bottle Cancelled under s30(1)(c)

4 December 2017

Cancellation by sponsor

Requested by Takeda Pharmaceuticals Australia Pty Ltd
NESINA PIO 12.5/15 12.5 mg alogliptin (as benzoate) / 15 mg pioglitazone (as hydrochloride) film-coated tablet bottle Cancelled under s30(1)(c)

4 December 2017

Cancellation by sponsor

Requested by Takeda Pharmaceuticals Australia Pty Ltd
NESINA PIO 12.5/45 12.5 mg alogliptin (as benzoate) / 45 mg pioglitazone (as hydrochloride) film-coated tablet bottle Cancelled under s30(1)(c)

4 December 2017

Cancellation by sponsor

Requested by Takeda Pharmaceuticals Australia Pty Ltd

Pages

First page
Previous page
…
Page 7
Page 8
Page 9
Page 10
Current page 11
Page 12
Page 13
Page 14
Page 15
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.